食管胃癌-话题@MedSci

#食管胃癌#

4篇内容 | 563人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2082968, encodeId=42382082968ca, content=<a href='/topic/show?id=2e03101113c7' target=_blank style='color:#2F92EE;'>#食管胃癌#</a>, objectTitle=Gastric Cancer：患者报告的生活质量在食管胃癌的生存预后作用：来自POCOP研究, objectType=article, longId=214518, objectId=765d214518fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=765d214518fd, replyNumber=0, likeNumber=45, createdTime=2021-09-05, rootId=0, userName=ms1467340776200723, userId=82ba2500166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=765d214518fd, moduleTitle=Gastric Cancer：患者报告的生活质量在食管胃癌的生存预后作用：来自POCOP研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=765d214518fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2082967, encodeId=c3bf208296e5b, content=<a href='/topic/show?id=2e03101113c7' target=_blank style='color:#2F92EE;'>#食管胃癌#</a>, objectTitle=Lancet Oncol：派姆单抗联合疗法一线治疗HER2阳性转移性食管胃癌, objectType=article, longId=194729, objectId=8973194e294c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8973194e294c, replyNumber=0, likeNumber=35, createdTime=2021-02-24, rootId=0, userName=ms1467340776200723, userId=82ba2500166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8973194e294c, moduleTitle=Lancet Oncol：派姆单抗联合疗法一线治疗HER2阳性转移性食管胃癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8973194e294c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2082966, encodeId=b46d2082966eb, content=<a href='/topic/show?id=2e03101113c7' target=_blank style='color:#2F92EE;'>#食管胃癌#</a>, objectTitle=2019 ESMO 瑞戈非尼120 mg联合紫杉醇二线治疗晚期食管胃癌，初显疗效, objectType=article, longId=180450, objectId=c1df1804504a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1df1804504a, replyNumber=0, likeNumber=30, createdTime=2020-07-31, rootId=0, userName=ms1467340776200723, userId=82ba2500166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1df1804504a, moduleTitle=2019 ESMO 瑞戈非尼120 mg联合紫杉醇二线治疗晚期食管胃癌，初显疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c1df1804504a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2082965, encodeId=eee520829655c, content=<a href='/topic/show?id=2e03101113c7' target=_blank style='color:#2F92EE;'>#食管胃癌#</a>, objectTitle=JCO：Nivolumab和Nivolumab联合Ipilimumab治疗转移性食管胃癌患者, objectType=article, longId=147192, objectId=187c14e1923f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=187c14e1923f, replyNumber=0, likeNumber=34, createdTime=2019-03-28, rootId=0, userName=ms1467340776200723, userId=82ba2500166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=187c14e1923f, moduleTitle=JCO：Nivolumab和Nivolumab联合Ipilimumab治疗转移性食管胃癌患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=187c14e1923f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

食管胃癌

2020-05-29

ms1467340776200723 (审核中...)

前往app查看评论内容

#食管胃癌#

Gastric Cancer：患者报告的生活质量在食管胃癌的生存预后作用：来自POCOP研究

2021-09-05

ms1467340776200723 (审核中...)

前往app查看评论内容

#食管胃癌#

Lancet Oncol：派姆单抗联合疗法一线治疗HER2阳性转移性食管胃癌

2021-02-24

ms1467340776200723 (审核中...)

前往app查看评论内容

#食管胃癌#

2019 ESMO 瑞戈非尼120 mg联合紫杉醇二线治疗晚期食管胃癌，初显疗效

2020-07-31

ms1467340776200723 (审核中...)

前往app查看评论内容

#食管胃癌#

JCO：Nivolumab和Nivolumab联合Ipilimumab治疗转移性食管胃癌患者

2019-03-28

科室
- - 订阅+
  - 更多科室
工具
服务